ClassID:

96898

C07K14/47 - page 12 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Recent Application in this class:
#3301
20140088024
2014-03-27

Vesiculins

#3302
20140087995
2014-03-27

Amylin analogs and pharmaceutical compositions thereof

#3303
20140086949
2014-03-27

Ghrelin mimetic polypeptide hapten immunoconjugates having improved solubility and immunogenicity and methods of use thereof

#3304
20140086835
2014-03-27

Methods and compositions for heptameric targeting ligands

#3305
20140081004
2014-03-20

Glycosylated specificity exchangers

#3306
20140079774
2014-03-20

Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same

#3307
20140079643
2014-03-20

Protein skeletal module which increases the binding affinity and binding specificity of active polypeptides

#3308
20140073576
2014-03-13

Methods of preventing or treating brain diseases

#3309
20140073572
2014-03-13

Targeting complement factor H for treatment of diseases

#3310
20140073555
2014-03-13

Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation

#3311
20140073518
2014-03-13

Fusion proteins comprising an engineered knottin peptide and uses thereof

#3312
20140072975
2014-03-13

Compositions and methods for determining genetic polymorphisms in the TMEM216 gene

#3313
20140072973
2014-03-13

gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis

#3314
20140072970
2014-03-13

Lafora's disease gene

#3315
20140066602
2014-03-06

Antibodies that specifically bind SOST and WISE peptides

#3316
20140066592
2014-03-06

Methods and compositions for the treatment of cancer or other diseases

#3317
20140066381
2014-03-06

Peptides that are modulators of the protein TRF2 and compositions containing same

#3318
20140065724
2014-03-06

Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides

#3319
20140065711
2014-03-06

Small molecule-dependent inteins and uses thereof

#3320
20140065669
2014-03-06

NEUROBLASTOMA HOST CELL LINE FOR STABLY EXPRESSING HUMAN EXOGENOUS PROTEIN AND METHOD

#3321
20140056906
2014-02-27

Antibody to secreted polypeptide

#3322
20140056904
2014-02-27

Antibodies to TTR and methods of use

#3323
20140056820
2014-02-27

Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof

#3324
20140051831
2014-02-20

Method for isolating osteopontin using feeds containing CMP or casein species

#3325
20140051645
2014-02-20

Muteins of human lipocalin 2 with affinity for CTLA-4

#3326
20140051630
2014-02-20

PERIOSTIN-INDUCED PANCREATIC REGENERATION

#3327
20140051096
2014-02-20

NUCLEIC ACID AND CORRESPONDING PROTEIN NAMED 158P1D7 USEFUL IN THE TREATMENT AND DETECTION OF BLADDER AND OTHER CANCERS

#3328
20140050713
2014-02-20

Chimeric antibacterial polypeptides

#3329
20140050693
2014-02-20

Biological active proteins having increased in vivo and/or in vitro stability

#3330
20140046025
2014-02-13

Device and method for production and analysis of prions

#3331
20140045775
2014-02-13

SHORT-FORM HUMAN MD-2 AS A NEGATIVE REGULATOR OF TOLL-LIKE RECEPTOR 4 SIGNALING

#3332
20140045757
2014-02-13

Compositions having antiangiogenic activity and uses thereof

#3333
20140045216
2014-02-13

Signal sequences to improve protein expressions and secretion of recombinant enzymes and other proteins

#3334
20140041066
2014-02-06

Production of FMDV-resistant livestock by allele substitution

#3335
20140039174
2014-02-06

Ribonucleic acid binding motif protein 20 sequence variants

#3336
20140039041
2014-02-06

FILIP1L nucleic acid fragments

#3337
20140038908
2014-02-06

Polynucleotides and Polypeptides Associated with Trophoblast Cell Death, Differentiation, Invasion and/or Cell Fusion and Turnover

#3338
20140038880
2014-02-06

Compositions and methods for promoting wound healing and tissue regeneration

#3339
20140038233
2014-02-06

Expression vector for animal cells

#3340
20140030742
2014-01-30

Antibody reacting with native Cochlin-tomoprotein (CTP) and method for measuring CTP using same

#3341
20140030274
2014-01-30

Methods of screening compounds for the fibril formation of Aβ peptides based on a decreased trimer/monomer ratio of a chaperone protein

#3342
20140024802
2014-01-23

Cyclic CRF antagonist peptides

#3343
20140017774
2014-01-16

PCA3 genes

#3344
20140017713
2014-01-16

Method of diagnosing cancer and diagnosis kit using measurement of NK cell activity

#3345
20140017251
2014-01-16

Botulinum neurotoxin a receptor and the use thereof

#3346
20140017201
2014-01-16

Viral vectors for the treatment of retinal dystrophy

#3347
20140011742
2014-01-09

Bioactive Peptides and Proteins Containing Bioactive Peptides, their Uses and Processes for Making the Same

#3348
20140011737
2014-01-09

Methods for treating metabolic syndrome with Cthrc1 polypeptide

#3349
20140011728
2014-01-09

LONG-ACTING IL-1 RECEPTOR ANTAGONISTS

#3350
20140010863
2014-01-09

LIPOSOMES FOR PROTECTION AGAINST TOXIC COMPOUNDS

#3351
20140010786
2014-01-09

USE OF HEPATOCYTE NUCLEAR FACTOR 1A IN PREPARATION OF DRUG FOR TREATING MALIGNANT SOLID TUMOR DISEASE

#3352
20140010757
2014-01-09

Imaging methods using engineered integrin binding peptides

#3353
20140005358
2014-01-02

Natriuretic polypeptides

#3354
20140005126
2014-01-02

SCAFFOLD PEPTIDES

#3355
20140005125
2014-01-02

Designed ankyrin repeat proteins binding to platelet-derived growth factor

#3356
20140005120
2014-01-02

Activity enhancer for anticancer agent

#3357
20140005118
2014-01-02

Beta-catenin targeting peptides and uses thereof

#3358
20140005107
2014-01-02

Apolipoprotein AIV as an antidiabetic peptide

#3359
20140005097
2014-01-02

Bioactive peptides and methods of using same

#3360
20140004136
2014-01-02

PHOSPHORYLATED DERIVATIVES OF A U1-70K PEPTIDE AND THEIR USE IN THE TREATMENT OF AUTOIMMUNE PATHOLOGIES

#3361
20140004129
2014-01-02

Novel Polypeptides Involved in Immune Response

#3362
20130345392
2013-12-26

EDN3-LIKE PEPTIDES AND USES THEREOF

#3363
20130345145
2013-12-26

ATIP3 AND BIOLOGICALLY ACTIVE FRAGMENTS THEREOF FOR USE IN THE TREATMENT OF CANCER

#3364
20130344161
2013-12-26

Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions for methods of treating tissue injury

#3365
20130340101
2013-12-19

Homeobox gene

#3366
20130338080
2013-12-19

COMPOSITIONS AND METHODS FOR TREATING AN ACTIVATED B-CELL DIFFUSE LARGE B-CELL LYMPHOMA

#3367
20130337540
2013-12-19

Class of therapeutic protein based molecules

#3368
20130337504
2013-12-19

Methods and compositions for producing active vitamin K-dependent proteins

#3369
20130337038
2013-12-19

Chimeric fibronectin matrix mimetics and uses therof

#3370
20130331282
2013-12-12

MARKER COMPOSITION COMPRISING S1P PROTEIN FOR PREDICTION OF RISK IN OSTEOPOROTIC FRACTURE AND OSTEOPOROSIS

#3371
20130330414
2013-12-12

Methods and compositions for treating inflammation

#3372
20130324483
2013-12-05

MAMMALIAN CELL SURFACE ANTIGENS; RELATED REAGENTS

#3373
20130324478
2013-12-05

Pharmacodiagnosis Test Targeting Oncology and Neurodegeneration

#3374
20130324477
2013-12-05

Peptides that modulate complex SASPase-FLG2

#3375
20130324474
2013-12-05

Variants of human GDNF

#3376
20130323813
2013-12-05

Peptides for the specific binding of RNA targets

#3377
20130323759
2013-12-05

Spinal muscular atrophy diagnostic methods

#3378
20130317087
2013-11-28

Methods and compositions related to Staufen 1 binding sites formed by duplexing Alu elements

#3379
20130316962
2013-11-28

Muteins of hNGAL and related proteins with affinity for a given target

#3380
20130316959
2013-11-28

Use of endostatin peptides for the treatment of fibrosis

#3381
20130316956
2013-11-28

NUCLEIC ACIDS ENCODING PEPTIDES FOR TREATING WOUNDS, ANTI-ANGIOGENIC COMPOUNDS AND USES THEREOF

#3382
20130316952
2013-11-28

Non-natural consensus albumin binding domains

#3383
20130316946
2013-11-28

EXTENDED RECOMBINANT POLYPEPTIDE-MODIFIED C-PEPTIDE

#3384
20130316911
2013-11-28

Methods and compositions for screening and treating developmental disorders

#3385
20130315942
2013-11-28

Method of inducing an immune response by administering WDRPUH epitope peptides

#3386
20130315879
2013-11-28

Method for expansion of stem cells and the use of such cells

#3387
20130310305
2013-11-21

Methods for increasing plasmin activity and promoting plaque regression in the treatment of atherosclerosis

#3388
20130310304
2013-11-21

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ATHEROSCLEROSIS

#3389
20130309259
2013-11-21

WDHD1 peptides and vaccines including the same

#3390
20130309252
2013-11-21

Antagonists of GRASP55 for use as a medicament

#3391
20130303744
2013-11-14

USP2A PEPTIDES AND ANTIBODIES

#3392
20130303598
2013-11-14

Methods of making antibodies that bind polypeptides involved in the process of bone remodeling

#3393
20130302886
2013-11-14

Pre-Ligand assembly domain of the IL-17 receptor

#3394
20130302876
2013-11-14

Transducible polypeptides for modifying metabolism

#3395
20130296258
2013-11-07

Muteins of human lipocalin 2 with affinity for glypican-3 (GPC-3)

#3396
20130296225
2013-11-07

Microcrystalline Y receptor agonists

#3397
20130296221
2013-11-07

Capping modules for designed ankyrin repeat proteins

#3398
20130295593
2013-11-07

Truncated human vitamin D binding protein and mutation and fusion thereof and related materials and methods of use

#3399
20130295005
2013-11-07

Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases

#3400
20130289252
2013-10-31

COMPOSITIONS AND METHODS FOR THE DELIVERY OF NITRIC OXIDE

#3401
20130288980
2013-10-31

TARGETING SENESCENT AND CANCER CELLS FOR SELECTIVE KILLING BY INTERFERENCE WITH FOXO4

#3402
20130288970
2013-10-31

COMPOSITIONS AND METHODS FOR THE DELIVERY OF OXYGEN

#3403
20130288364
2013-10-31

ENGINEERED KINETOCHORES AND USES THEREOF

#3404
20130288363
2013-10-31

SPARC-derived tumor rejection antigenic peptides and medicaments comprising the same

#3405
20130287839
2013-10-31

Use of the cathelicidin LL-37 and derivatives thereof for wound healing

#3406
20130287784
2013-10-31

Compositions Targeting the Soluble Extracellular Domain of E-Cadherin and Related Methods for Cancer Therapy

#3407
20130281659
2013-10-24

Well-defined oligomers of ubiquitin and ubiquitin-like polypeptides, and methods for preparing same

#3408
20130281374
2013-10-24

DPP-IV RESISTANT GIP HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES

#3409
20130280746
2013-10-24

Peptide-lipid constructs and their use in diagnostic and therapeutic applications

#3410
20130280173
2013-10-24

Reporter genes for magnetic resonance imaging and methods of use thereof

#3411
20130274206
2013-10-17

Compositions and methods for promoting wound healing and tissue regeneration

#3412
20130273653
2013-10-17

DIAGNOSTIC MARKER FOR MELANOMA, PHARMACEUTICAL COMPOSITION COMPRISING INHIBITOR OF THE FUNCTION OF THE HISTATIN-1 PROTEIN AND IMMUNOSUPPRESSOR

#3413
20130273550
2013-10-17

Methods and vectors for cell immortalisation

#3414
20130267543
2013-10-10

Substituted 1,3-thiazoles as heat shock transcription factor 1 activators

#3415
20130267025
2013-10-10

Partial Region Polypeptide of REIC/Dkk-3 Protein

#3416
20130267013
2013-10-10

Methods for isolation, use and analysis of ferritin

#3417
20130261061
2013-10-03

Method of enhancing efficacy of blood transfusions

#3418
20130261053
2013-10-03

Glial cell line-derived neurotrophic factor (GDNF) compositions and use thereof

#3419
20130259924
2013-10-03

Modified polynucleotides for the production of biologics and proteins associated with human disease

#3420
20130259923
2013-10-03

Modified polynucleotides for the production of secreted proteins

#3421
20130259802
2013-10-03

Radiofluorinated compounds and their preparation

#3422
20130259801
2013-10-03

SERUM AMYLOID P PROTEIN

#3423
20130254908
2013-09-26

MO-1, A Gene Associated With Morbid Obesity

#3424
20130252905
2013-09-26

PLIF multimeric peptides and uses thereof

#3425
20130245238
2013-09-19

Fibronectin binding domains with reduced immunogenicity

#3426
20130245100
2013-09-19

Polynucleotide for use in treatment of influenza A virus induced diseases, encoding modified Mx protein, said modified Mx protein, and a transgenic animal expressing gene encoding modified Mx protein

#3427
20130244955
2013-09-19

Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins that bind hepcidin and nucleic acid encoding such

#3428
20130244946
2013-09-19

Compositions for treatment of neurodegenerative diseases

#3429
20130244940
2013-09-19

Designed repeat proteins binding to serum albumin

#3430
20130244938
2013-09-19

Method of inducing labor or treating pre-eclampsia by administering relaxin analogs

#3431
20130244928
2013-09-19

Antimicrobial peptides and derived metapeptides

#3432
20130244927
2013-09-19

Compositions comprising signal peptide-containing proteins

#3433
20130244324
2013-09-19

Use of GDF traps to treat anemia

#3434
20130244323
2013-09-19

Mammalian cell expressing light-activated ion channel protein (VChR1)

#3435
20130243755
2013-09-19

Human ULIP/CRMP protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes

#3436
20130237474
2013-09-12

Biosynthetic Polypeptide Fusion Inhibitors

#3437
20130236956
2013-09-12

Nucleic acid fragments from a ribosomal protein promoter for enhancing gene expression

#3438
20130236913
2013-09-12

Serological markers for detecting colorectal cancer and their application for inhibiting colorectal cancer cells

#3439
20130236404
2013-09-12

Substances and compositions for enhancing DNA repair and methods of use

#3440
20130231280
2013-09-05

Novel Peptide Involved in Energy Homeostasis

#3441
20130230562
2013-09-05

Fusion protein comprising small heat shock protein, cage protein formed thereby, and novel use thereof

#3442
20130230532
2013-09-05

Myomegalin variant 8

#3443
20130230488
2013-09-05

Method for inducing immunity with a peptide fragment from human CAPRIN-1

#3444
20130225666
2013-08-29

Delivery of MECP2 polynucleotide using recombinant AAV9

#3445
20130225503
2013-08-29

TEX14 PEPTIDES AS NOVEL ANTITUMOR AGENTS

#3446
20130225436
2013-08-29

Specific active site inhibitors of enzymes and methods of producing same

#3447
20130217867
2013-08-22

Recombinant production of vascular endothelial growth factor

#3448
20130217637
2013-08-22

Mutant NGAL proteins and uses thereof

#3449
20130217616
2013-08-22

Chimeric inhibitor molecules of complement activation

#3450
20130217067
2013-08-22

Combinatorial DNA library for producing modified N-glycans in lower eukaryotes

#3451
20130216563
2013-08-22

Immunogenic Polypeptides Encoded by MAGE Minigenes and Uses Thereof

#3452
20130216539
2013-08-22

Methods of Generation and Treatment with Modified Derivatives of HSP 70

#3453
20130216479
2013-08-22

SITE-SPECIFIC CHEMICAL MODIFICATION OF PROTEINS AT THEIR N-TERMINI, ENABLING THE FORMATION OF HOMOGENEOUS ADDUCTS

#3454
20130210741
2013-08-15

Immunoregulatory peptides and methods of use

#3455
20130209462
2013-08-15

Cerberus/Coco derivatives and uses thereof

#3456
20130203683
2013-08-08

Immunoregulatory peptides and methods of use

#3457
20130203679
2013-08-08

Immunoregulatory peptides and methods of use

#3458
20130203648
2013-08-08

Preparation of recombinant human plasma phospholipid transfer protein (PLTP) from the milk of transgenic rabbits

#3459
20130203164
2013-08-08

Human Secreted Proteins

#3460
20130203060
2013-08-08

MAMMALIAN GENES; RELATED REAGENTS

#3461
20130202600
2013-08-08

Methods for modulating D1-D2 dopamine receptor coupling and function

#3462
20130202593
2013-08-08

INTRACELLULAR IMMUNITY

#3463
20130197068
2013-08-01

RNA containing modified nucleosides and methods of use thereof

#3464
20130196933
2013-08-01

Methods and compositions inhibiting tumor cell proliferation

#3465
20130196932
2013-08-01

Frataxin mutants

#3466
20130196930
2013-08-01

Polynucleotides encoding recombinant lubricin molecules and uses thereof

#3467
20130196929
2013-08-01

SECRETED PROTEIN ACIDIC AND RICH IN CYSTEINE (SPARC) AS CHEMOTHERAPEUTIC SENSITIZERS

#3468
20130196926
2013-08-01

Controlled release of ocular biopharmaceuticals using bioresponsive protein polymers

#3469
20130196925
2013-08-01

Compositions and methods useful in enhancement of memory

#3470
20130196871
2013-08-01

Fibronectin binding domains with reduced immunogenicity

#3471
20130195902
2013-08-01

Recombinant allergen

#3472
20130195763
2013-08-01

METHODS AND COMPOSITIONS FOR IMPROVING SLEEP AND MEMORY

#3473
20130195760
2013-08-01

Chlorotoxin variants, conjugates, and methods for their use

#3474
20130190240
2013-07-25

TUMOR GROWTH CONTROLLING METHOD TARGETING GALACTOSYLCERAMIDE EXPRESSION FACTOR-1

#3475
20130189284
2013-07-25

ANTIBODIES WITH T-CELL RECEPTOR LIKE SPECIFICITY TOWARDS NATIVE COMPLEXES OF MHC CLASS II AND DIABETES-ASSOCIATED AUTOANTIGENIC PEPTIDES

#3476
20130183691
2013-07-18

Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis

#3477
20130183265
2013-07-18

MIA-2 PROTEIN

#3478
20130177919
2013-07-11

PROTEIN PRODUCTION

#3479
20130177545
2013-07-11

Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and applications thereof

#3480
20130172262
2013-07-04

Compound and method for treatment of alzheimer's disease and familial dementia

#3481
20130172251
2013-07-04

Modified ghrelin peptides

#3482
20130171235
2013-07-04

Use of -long leader sequence for transmembrane delivery of molecules

#3483
20130171157
2013-07-04

NOGO Receptor-Mediated Blockade of Axonal Growth

#3484
20130171074
2013-07-04

TARGETING COMPOUNDS

#3485
20130165391
2013-06-27

β2-glycoprotein I peptide inhibitors

#3486
20130165388
2013-06-27

Method for treating wrinkles using a paralytic peptide from the shrew

#3487
20130165385
2013-06-27

Neurogenin

#3488
20130164254
2013-06-27

Anticancer fusion protein comprising trail

#3489
20130164219
2013-06-27

Cell-penetrating peptides and uses thereof

#3490
20130158095
2013-06-20

EML4-ALK fusion gene

#3491
20130157878
2013-06-20

Method for identifying hetero-multimeric modified ubiquitin proteins with binding capability to ligands

#3492
20130157338
2013-06-20

RHAMM binding peptides

#3493
20130157311
2013-06-20

Methods of determination of activation or inactivation of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) hormonal systems

#3494
20130157284
2013-06-20

Colorimetric and fluorescent proteins

#3495
20130156819
2013-06-20

ISOLATION OF MESENCHYMAL STEM CELLS

#3496
20130156765
2013-06-20

FUSION PROTEINS OF NATURAL HUMAN PROTEIN FRAGMENTS TO CREATE ORDERLY MULTIMERIZED IMMUNOGLOBULIN Fc COMPOSITIONS

#3497
20130156704
2013-06-20

Therapy for subarachnoid hemorrhage and ischemia

#3498
20130156697
2013-06-20

ISOLATED PROTEIN MEDICAMENT

#3499
20130156694
2013-06-20

HSP70 fusion protein conjugates and uses thereof

#3500
20130145484
2013-06-06

Antibody producing non-human mammals

#3501
20130143299
2013-06-06

RNF8-FHA domain-modified protein and method of producing the same

#3502
20130143294
2013-06-06

Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers

#3503
20130137758
2013-05-30

Akt activity specifically inhibiting polypeptide

#3504
20130137096
2013-05-30

Diagnosis of hereditary spastic paraplegias (HSP) by identification of a mutation in the ZFYVE26 gene or protein

#3505
20130130971
2013-05-23

Method for inhibiting HIV replication in mammal and human cells

#3506
20130123467
2013-05-16

Engineering surface epitopes to improve protein crystallization

#3507
20130123200
2013-05-16

MAMMALIAN CELL SURFACE ANTIGENS; RELATED REAGENTS

#3508
20130123199
2013-05-16

Protein complex for intracellular delivery and uses thereof

#3509
20130123187
2013-05-16

PEPTIDES FOR THE REGULATION OF NEUROTRANSMITTER SEQUESTRATION AND RELEASE

#3510
20130123122
2013-05-16

Tango 240 nucleic acids and uses thereof

#3511
20130116409
2013-05-09

Method for Enriching Methylated CpG Sequences

#3512
20130116201
2013-05-09

Use of peptides as transporters intended for the internalization of molecules of interest into target cells

#3513
20130115603
2013-05-09

NUCLEOTIDE REPEAT EXPANSION-ASSOCIATED POLYPEPTIDES AND USES THEREOF

#3514
20130111613
2013-05-02

COLON DISEASE TARGETS AND USES THEREOF

#3515
20130109587
2013-05-02

USP2a peptides and antibodies

#3516
20130108662
2013-05-02

Peptides useful as cell-penetrating peptides

#3517
20130108654
2013-05-02

Telomerase activity inhibiting peptide and manufacturing method and application thereof

#3518
20130102544
2013-04-25

Disease-associated proteins

#3519
20130096065
2013-04-18

NEUBLASTIN VARIANTS

#3520
20130095475
2013-04-18

Genes from 20q13 amplicon and their uses

#3521
20130095110
2013-04-18

Hyaluronic acid decomposition-promoting factor and inhibitor thereof

#3522
20130095107
2013-04-18

BIOMARKER SPECIFIC TO BRAIN/NERVE OR SPECIFIC TO NEURONAL DIFFERENTIATION

#3523
20130095075
2013-04-18

Bone morphogenic protein binding peptide

#3524
20130085113
2013-04-04

Tear lipocalin in muteins binding IL-4 R alpha

#3525
20130084582
2013-04-04

SEROLOGICAL MARKERS FOR DETECTING COLORECTAL CANCER AND THEIR APPLICATION FOR INHIBITING COLORECTAL CANCER CELLS

#3526
20130084327
2013-04-04

Polynucleotide encoding a TRIM-cyp polypeptide, compositions thereof, and methods of using same

#3527
20130079286
2013-03-28

Muteins of human lipocalin 2 (LcnC,hNGAL) with affinity for a given target

#3528
20130078183
2013-03-28

Multiple signaling pathways induced by hexvalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases

#3529
20130074201
2013-03-21

CANCER-SPECIFIC GENETIC REARRANGEMENTS

#3530
20130074199
2013-03-21

Compositions and methods for brown fat induction and activity using FNDC5

#3531
20130072667
2013-03-21

Use of RGM and its modulators

#3532
20130072581
2013-03-21

Secreted protein acidic and rich in cysteine (SPARC) protein SRM assay

#3533
20130071392
2013-03-21

Small heat shock proteins and active fragments thereof as a therapy for inflammation and ischemia

#3534
20130067608
2013-03-14

COLON CANCER TARGETS AND USES THEREOF

#3535
20130067603
2013-03-14

Sperm-specific cation channel, CatSper4, and uses therefor

#3536
20130066060
2013-03-14

Gene for Identifying Individuals with Familial Dysautonomia

#3537
20130066052
2013-03-14

UCP4

#3538
20130066050
2013-03-14

CHLAMYDOMONAS INTRAFLAGELLAR TRANSPORT 88 (IFT-88)

#3539
20130065819
2013-03-14

Target of EGR1 (TOE1) polypeptides for inhibition of HIV

#3540
20130065817
2013-03-14

Polypeptide acting to enhance ischemic diseases

#3541
20130065792
2013-03-14

INDUCIBLE EXPRESSION OF SGLT5, METHODS AND KITS USING THE SAME

#3542
20130065244
2013-03-14

Method for producing cAMP using chimeric olfactory receptor

#3543
20130064818
2013-03-14

Use of immunesuppressant receptor

#3544
20130060003
2013-03-07

Chemical preparation of polyubiquitin chains

#3545
20130059792
2013-03-07

Traceability of cellular cycle anomalies targeting oncology and neurodegeneration

#3546
20130059757
2013-03-07

Gene targets associated with amyotrophic lateral sclerosis and methods of use thereof

#3547
20130059752
2013-03-07

Compositions and methods for the treatment of immune related diseases

#3548
20130059305
2013-03-07

Translocation and mutant ROS kinase in human non-small cell lung carcinoma

#3549
20130059304
2013-03-07

TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA

#3550
20130058924
2013-03-07

HYPOXIA-RELATED GENE SIGNATURES FOR CANCER CLASSIFICATION

#3551
20130053327
2013-02-28

Polypeptide expressed in the stratum corneum and thereof

#3552
20130053321
2013-02-28

Inhibitors of mitochondrial fission and methods of use thereof

#3553
20130052699
2013-02-28

Biocatalysts for ezetimibe synthesis

#3554
20130052667
2013-02-28

Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers

#3555
20130045916
2013-02-21

TREATMENT OF TYPE 2 DIABETES, METABOLIC SYNDROME, MYOCARDIAL INJURY AND NEURODEGENERATION WITH HUMANIN AND ANALOGS THEREOF

#3556
20130045537
2013-02-21

METHODS AND COMPOSITIONS RELATING TO MULTICILIATE CELL DIFFERENTIATION

#3557
20130045233
2013-02-21

Allergen

#3558
20130045212
2013-02-21

Biological Materials and Uses Thereof

#3559
20130041132
2013-02-14

Chemical preparation of ubiquitin thioesters and modifications thereof

#3560
20130041131
2013-02-14

Glycosylated specificity exchangers

#3561
20130039935
2013-02-14

Induction of tumor immunity by variants of folate binding protein

#3562
20130039914
2013-02-14

NOVEL HUMAN GENES RELATING TO RESPIRATORY DISEASES AND OBESITY

#3563
20130035260
2013-02-07

GENES INVOLVED IN INFLAMMATORY BOWEL DISEASES AND USE THEREOF

#3564
20130034561
2013-02-07

ISOLATED MAMMALIAN MONOCYTE CELL GENES; RELATED REAGENTS

#3565
20130034547
2013-02-07

Reliable stabilization of N-linked polypeptide native states with enhanced aromatic sequons located in polypeptide tight turns

#3566
20130029912
2013-01-31

Treatment of paroxysmal nocturnal hemoglobinuria, hemolytic anemias and disease states involving intravascular and extravascular hemolysis

#3567
20130029865
2013-01-31

Stromal Antigen 2 (STAG2) Compositions and Methods

#3568
20130029367
2013-01-31

COMPOSITIONS AND METHODS FOR MONITORING BREAST CANCER TREATMENT

#3569
20130029359
2013-01-31

Monoclonal antibodies and diagnostic uses thereof

#3570
20130028863
2013-01-31

Promyelocytic leukemia protein as a redox sensor

#3571
20130023651
2013-01-24

Antibody to peptide

#3572
20130022613
2013-01-24

WISE/SOST NUCLEIC ACID SEQUENCES AND AMINO ACID SEQUENCES

#3573
20130017996
2013-01-17

Muteins of tear lipocalin and methods for obtaining the same

#3574
20130017224
2013-01-17

Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same

#3575
20130017213
2013-01-17

Peptide analogues

#3576
20130012690
2013-01-10

METHOD FOR STABILIZATION OF PROTEINS USING NON-NATURAL AMINO ACIDS

#3577
20130011867
2013-01-10

BLADDER CANCER BIOMARKER AND TEST METHOD USING THE SAME

#3578
20130011422
2013-01-10

Tumor Antigens for the Prevention and/or Treatment of Cancer

#3579
20130011334
2013-01-10

Modified ubiquitin proteins having a specific binding activity for the extradomain B of fibronectin

#3580
20130005651
2013-01-03

DEATH ASSOCIATED PROTEIN 1 VARIANTS AND USE THEREOF FOR MODULATING AUTOPHAGY

#3581
20130004541
2013-01-03

Polymer nanofiber scaffold for a heparin / fibrin based growth factor delivery system

#3582
20130004512
2013-01-03

NUCLEIC ACID MOLECULES ENCODING BANK1 SPLICE VARIANTS

#3583
20130004431
2013-01-03

Transport agents for crossing the blood-brain barrier and into brain cancer cells and methods of use thereof

#3584
20120329733
2012-12-27

METHODS AND PRODUCTS RELATED TO METABOLIC INTERACTIONS IN DISEASE

#3585
20120329723
2012-12-27

Biological Agents Active in Central Nervous System

#3586
20120329719
2012-12-27

Methods of use of skin wound healing compositions

#3587
20120329670
2012-12-27

EPITOPE TESTING USING SOLUBLE HLA

#3588
20120329112
2012-12-27

Microorganisms having enhanced tolerance to inhibitors and stress

#3589
20120329080
2012-12-27

ANTI-HLA ASSAY AND METHODS

#3590
20120329066
2012-12-27

Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

#3591
20120322852
2012-12-20

SMNdelta7 degron: novel compositions and methods of use

#3592
20120321649
2012-12-20

Peptide vaccines for cancers expressing tumor-associated antigens

#3593
20120315634
2012-12-13

Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues

#3594
20120309939
2012-12-06

Production of Therapeutic Proteins in Photosynthetic Organisms

#3595
20120309692
2012-12-06

Activation of peptide prodrugs by hK2

#3596
20120309091
2012-12-06

Methods and compositions for gene inactivation

#3597
20120308603
2012-12-06

DNA vaccine against virus of yellow fever

#3598
20120308590
2012-12-06

IMP-3 OLIGOPEPTIDES AND VACCINES INCLUDING THE SAME

#3599
20120308570
2012-12-06

METHODS FOR TREATING DISEASES

#3600
20120308561
2012-12-06

Method for inhibiting bone resorption